Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM) -- Ignore unavailable to you. Want to Upgrade?

To: Rob who wrote (364)	12/29/2000 5:39:39 PM
From: Starowl	Read Replies (1) \| Respond to of 655

Well, the old reverse split trick. Anybody see anything good in this? Maybe even a new name: "Response Diagnostics"? "FOR IMMEDIATE RELEASE Canadian Venture Exchange: RBM "RESPONSE BIOMEDICAL SEEKS SHAREHOLDER APPROVAL FOR NEXT STEP IN FINANCING STRATEGY "Vancouver, British Columbia, December 29, 2000 - Response Biomedical Corp. today announced that, as part of its long term financing strategy, the shareholders of the Company will be asked to approve a name change and a consolidation of the share capital at an Extraordinary General Meeting to be held on March 1, 2001. The consolidation will be on the basis of up to three old shares for one new share. "Consolidating the outstanding share capital of the Company is an important step in the financing plan we initiated earlier this month", President and CEO Humberto Reyes stated. "We are confident that this step will facilitate our long term financing strategy." "As of December 29, 2000, the issued and outstanding share capital of the Company was 27,323,148 shares on an undiluted basis. Outstanding warrants and stock options raise the fully diluted share capital to 35,200,805 shares. Assuming a consolidation ratio of three to one, the issued and outstanding shares of the re-capitalized company would be 9,107,716 shares on an undiluted basis."